KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Receivables: 2014-2017

Historic Change in Receivables for Palvella Therapeutics (PVLA) over the last 2 years, with Dec 2017 value amounting to $12.1 million.

  • Palvella Therapeutics' Change in Receivables was N/A to $12.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $14.5 million, marking a year-over-year change of. This contributed to the annual value of -$5.3 million for FY2023, which is 302.25% down from last year.
  • According to the latest figures from Q4 2017, Palvella Therapeutics' Change in Receivables is $12.1 million, which was up 127.48% from -$44.1 million recorded in Q3 2017.
  • In the past 5 years, Palvella Therapeutics' Change in Receivables registered a high of $46.5 million during Q2 2017, and its lowest value of -$44.1 million during Q3 2017.
  • Over the past 2 years, Palvella Therapeutics' median Change in Receivables value was $68,870 (recorded in 2016), while the average stood at $2.9 million.
  • Data for Palvella Therapeutics' Change in Receivables shows a maximum YoY plummeted of 128.06% (in 2017) over the last 5 years.
  • Quarterly analysis of 3 years shows Palvella Therapeutics' Change in Receivables stood at -$474,418 in 2014, then reached $68,870 in 2016, then tumbled by 128.06% to $12.1 million in 2017.
  • Its Change in Receivables was $12.1 million in Q4 2017, compared to -$44.1 million in Q3 2017 and $46.5 million in Q2 2017.